| abstract |
Disclosed herein are compositions and methods for the treatment of otic disorders with apoptosis modulating agent compositions and compositions administered locally to an individual afflicted with an otic disorder, through direct application of these compositions and compositions onto or via perfusion into the targeted auris structure(s). |